Protecting health workers from nosocomial Hepatitis B infections: A review of strategies and challenges for implementation of Hepatitis B vaccination among health workers in Sub-Saharan Africa  by Malewezi, Bridget et al.
Journal of Epidemiology and Global Health (2017) 6, 229–241HO ST E D  BYhttp : / / www.elsev ier .com/ locate / jeghREVIEW ARTICLEProtecting health workers from nosocomial
Hepatitis B infections: A review of
strategies and challenges for
implementation of Hepatitis B vaccination
among health workers in Sub-Saharan
Africahttp://dx.doi.org/10.1016/j.jegh.2016.04.003
2210-6006/ 2016 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
⇑ Corresponding author at: 1518 Clifton Road, Atlanta, GA 30322, USA.
E-mail address: bridget.malewezi@emory.edu (B. Malewezi).
Peer review under responsibility of Ministry of Health, Saudi Arabia.Bridget Malewezi a,⇑, Saad B. Omer a,b,c, Beatrice Mwagomba d,
Trish Araru daHubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA
bDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA
c Emory Vaccine Center, Atlanta, GA, USA
dMinistry of Health, Capital City, Lilongwe 3, MalawiReceived 31 August 2015; received in revised form 1 April 2016; accepted 13 April 2016
Available online 4 May 2016KEYWORDS
Africa;
Health worker;
Hepatitis B;
Hepatitis B vaccineAbstract The Sub-Saharan region has the highest Hepatitis B virus (HBV) rates, and
health workers are at an increased risk of contracting nosocomial HBV infection.
Vaccination of health workers plays a critical role in protecting them from sequelae
of HBV; however, health-worker vaccination remains a challenge for many coun-
tries. This study was conducted to review practices/measures and challenges in
the Sub-Saharan region relating to vaccination of health workers against HBV. We
performed a literature review of articles addressing any aspect of HBV vaccination
of health workers in the Sub-Saharan region sourced from PubMed, Embase, and Web
of Science, including a case study of Malawi policies and strategies in training insti-
tutions and facilities. Our findings indicated that HBV awareness and vaccination
were relatively high, but vaccination rates were lower, with 4.6–64.4% of those
‘‘ever vaccinated” completing the vaccination regimen. There was also great vari-
ation in the proportion of health workers exhibiting natural immunity from previous
exposure (positive for anti-Hepatitis B core antibodies; 41–92%). Commonly cited
reasons for non-uptake of vaccine included cost, lack of awareness of vaccine
230 B. Malewezi et al.availability, and inadequate information concerning the vaccine. Countries in this
region will require locally relevant data to develop cost-effective strategies that
maximize the benefit to their health workers due to the great diversity of HBV epi-
demiology in the region.
 2016 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Contents
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Health workers are at an increased risk of contract-
ing Hepatitis B virus (HBV) in the workplace due to
their potential contact with infected bodily fluids,
such as blood, saliva, or vaginal fluids [1]. World-
wide, HBV is estimated to have infected >2 billion
people and causes 0.5 million deaths annually [2].
Mortality is mainly due to sequelae of chronic
infection, such as liver cirrhosis and liver cancer.
Prevalence of HBV infection among health workers
depends upon the rates of HBV infection in the
region where they work, but studies reported rates
between 0.8% and 74.4% [3–5]. The World Health
Organization (WHO) has recommended that high-
risk groups, including health workers, be targeted
for routine provision of HBV vaccine to protect
them from infection. Despite the fact that health
workers are an accessible and easily identifiable
population in which to implement vaccination
strategies, many countries (including those in the
West) face challenges in addressing at-risk target
groups [6,7], and 24% of the health workforce
worldwide remain unvaccinated against HBV [8].The Sub-Saharan region has the highest HBV
rates, ranging from 5% to 8% [9–11], with high
human immunodeficiency virus (HIV) and HBV co-
infection (15%) rates [2,12–15]. The region also
faces critical shortages of health workers; despite
shouldering 24% of the global disease burden, it
has only 3% of the global health workforce [16].
Morbidity and mortality related to chronic dis-
eases, such as HIV [17,18] and potentially HBV,
contribute to high attrition among health workers.
While many of these countries have imple-
mented universal HBV vaccination for infants
[19], there is limited visibility on what is happening
related to protecting health workers from an infec-
tion that can be easily prevented with a three-dose
regimen of the HBV vaccine. This review provides
an insight into practices/measures currently in
place in the Sub-Saharan region addressing vacci-
nation of health workers against HBV. We also high-
light key challenges and gaps pertinent in this
region in the hope that this information can help
guide implementing governments to protect health
workers from a preventable cause of significant
morbidity and mortality.
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A literature search was conducted in PubMed, Web
of Science, and Embase using medical subject
heading terms. Studies that addressed aspects of
HBV vaccine in health workers in the Sub-Saharan
region were identified. Exclusion criteria included
studies conducted in regions outside the Sub-
Saharan region, including the five African countries
not considered Sub-Saharan (i.e., Algeria, Egypt,
Libya, Morocco, and Tunisia) those > 15-year old
(i.e., published earlier than 2000). All study types
were eligible for inclusion in the review. A total
of 41 studies were identified, 33 of which had full
text available [7,20–51]. HBV-specific data were
extracted in Excel (Microsoft Corp, Bellevue, WA,
USA) and analyzed in SAS version 9.4 (SAS, Cary,
NC, USA).
Given the wide variability of definitions/mea-
sures of knowledge in the studies reviewed, aware-
ness of HBV was defined as the proportion of
respondents that ‘‘knew of HBV as a potential
occupational risk”, and awareness of HBV vaccine
was defined as the proportion of respondents
‘‘who knew of the existence of the HBV vaccine”.
Other aspects of knowledge, including transmis-
sion, vaccine characteristics/dosing, and catego-
rization of good versus poor knowledge, were
inconsistently reported and were not extracted
for review. Vaccination status was defined on two
levels: ever vaccinated (i.e., proportion of respon-
dents who had received at least one dose of vac-
cine and complete vaccination (defined as receipt
of all three doses, regardless of whether they had
post-vaccination immune testing).
For a more in-depth focus, Malawi, a country in
the southeastern region of the continent, was used
as a case-study country. Policies addressing various
aspects of the health sector were reviewed, as well
as email questionnaires of sampled health-worker
training institutions and districts. Four training
institutions were sampled in order to provide infor-
mation on vaccination of student health workers,
with three institutions providing responses. Three
districts out of 28 were sampled, with two provid-
ing responses.
3. Results
The 33 studies represented 17 out of the 47 Sub-
Saharan African countries, most of which were con-
ducted in Nigeria (n = 13). The majority of the
studies were cross-sectional, focusing mainly on
vaccination status (n = 29) among doctors and
nurses, but some also included other cadres, suchas paramedical, support staff, and students
(Table 1).
3.1. Awareness and vaccination rates
Generally, awareness of HBV as an occupational
risk and existence of the HBV vaccine was rela-
tively high among health workers, with HBV aware-
ness ranging between 52.0% [20] and 98.3% [24] and
vaccine awareness ranging between 70.2% [21] and
98% [38]. However, vaccination rates were lower,
with ‘‘ever vaccinated” rates ranging from 0%
among medical-waste handlers in Ethiopia [45] to
91.9% in a study where a hospital in Nigeria intro-
duced an HBV vaccination campaign for all staff
[34]. Despite these wide ranges, the majority of
studies found rates of 35–65% (Fig. 1). Completion
of all three doses was much lower, ranging
between 4.6% [7] and 64.4% [48], with post-
vaccination immune testing ranging between 0%
[20,46,48] and 12.7% [36] (Table 2).
3.2. HBV immunology
Seven studies assessed laboratory-based markers of
HBV [7,27–29,42,43,48]. There was great variabil-
ity in the immunological status of health workers,
with the range of anti-HBC (indicating natural
immunity from exposure to HBV infection) from
41% in Kenya [48] to 92% in Niger [43]. Acute infec-
tion and chronic carriage as determined by detec-
tion of HBV surface antigen ranged between 4%
[48] and 25.7% [27] (Table 2).
3.3. Strategies and challenges
Only two studies reported on mandatory vaccina-
tion, including a subset of nurses in the Tshwane
metro region [30] and some training institutions
[35] in South Africa, but did not include compar-
isons of vaccination rates between mandatory ver-
sus voluntary participants. Vaccines were provided
free of charge in most settings, but where health
workers had to pay for vaccination, cost was often
cited as a reason for non-uptake. Lack of aware-
ness of vaccine availability in the institution/coun-
try, lack of time, and inadequate vaccine
information were other commonly cited reasons.
While HBV vaccination was generally acceptable
in most of the studies, some health workers did
not see its importance, and others feared the side
effects of the vaccine.
Only two studies specifically targeted improved
uptake of HBV vaccine, with one based in a hospital
in Nigeria [34] and the other in a district in
Kenya [48]. Both utilized an increased
Table 1 Characteristics of studies on HBV vaccine in Sub-Saharan African health workers from 2000–2015 (n = 33).
Countries where studies were conducted
Nigeria 13
South Africa 5
Cameroon 4
Ethiopia 3
Kenya 2
Togo 1
Burkina Faso 1
Niger 1
Sudan 1
Uganda 1
Combined regionala 1
Study setting
Health facility (hospital/clinic) 14
Training institution 4
District level 8
National level 6
Regional level 1
Year of publication
2000–2004 6
2005–2009 6
2010–2015 21
Study type
Cross sectional 29
Cohort 1
Quasi experimental 2
Policy review 1
Sample size
<50 2
50–100 8
101–500 17
>500 4
Cadres covered
Single cadre 11
Multiple cadres 22
Doctors (any specialty) 24
Nurses 21
Dentists 16
Paramedical (lab/auxiliaries/clinical officers) 19
Support staff (cleaners/waste handlers) 11
Administrative staff (no contact with patients or materials/accounts, etc.) 6
Students (medical/nursing/dentist) 10
Aspect of HBV addressed
Awareness of HBV and vaccine 9
HBV vaccination status 29
HBV lab-based markers 7
Otherb 10
HBV, Hepatitis B virus.
a Combined region includes Cameroon, Ethiopia, Ghana, Kenya, Madagascar, Malawi, Mozambique, Nigeria, Rwanda, South
Africa, Sudan, Tanzania, Uganda, and Zambia.
b Predictors of uptake/policy/risk perception/challenges.
232 B. Malewezi et al.awareness/education of HBV, followed by achieve-
ment of vaccines being provided free on a volun-tary basis, ‘‘ever vaccinated” rates of 91.9% and
81.8%, and completion rates of 50.3% and 64.4%,
Table 2 Summary of key findings of studies on HBV vaccination of health workers from Sub-Saharan Africa from 2000 to
2015 (n = 33).
Variable Lowest value (%) Highest value (%) No. of studies
Awareness of HBV 52.0 98.3 8
Awareness of HBV vaccine 70.2 98.0 5
Vaccination status (‘‘ever vaccinated”) 0.0 91.9 29
Vaccination status (complete vaccination) 4.6 64.4 18
Vaccination status (immune testing) 0.0 12.7 8
Lab-based markers overall 60.1 76.6 2
HBsAg 4.0 25.7 6
Anti-HBS 22.2 61.6 3
Anti-HBC 41.0 92.0 5
Reasons for non-vaccination (n = 10) No. of studies citing reason
Cost 8
Unaware available 7
Inadequate information 6
Time 3
Vaccine not important 3
Ignorance 2
No reason 2
Potential side effects 2
No policy in place 1
Low-risk perception 1
Anti-HBC, Hepatitis B core antibody; Anti-HBS, Hepatitis B surface antibody; HBV, Hepatitis B virus; HBsAg, Hepatitis B surface
antigen.
Fig. 1 Boxplot of ‘‘ever vaccinated” vaccination status of Sub-Saharan health workers in studies that provided
estimates of vaccination rates from 2000 to 2005 (n = 29).
African health worker HBV vaccination 233respectively. The Kenya study utilized pre-
vaccination testing for anti-HBC to determine vac-
cination eligibility.
A key gap identified in several studies was the
lack of comprehensive strategies for targeting
health workers, resulting in inconsistent policies
and implementation, lack of treatment options
for infected health workers, and overall poor
uptake of vaccine.3.4. Malawi case study
There is no specific policy and no dedicated depart-
ment overseeing issues of hepatitis in Malawi. The
current 5-year strategic plan guiding prioritization
of all activities in the health sector [52] does not
mention hepatitis for health workers or the society
overall. While HBV vaccination has been universally
provided to infants in a combination vaccine (Pen-
Table 3 Key documents related to the health sector in Malawi highlighting the provisions made for health workers or HBV.
No mention of HBV
Guiding health-sector practice
Document Year Provisions
Health sector strategic plan 2011–2016 Guide prioritization of diseases and strategies for health sector
Health promotion policy 2013 Prioritization of diseases and strategies to promote public health
Public health act 1976 Guide actions for diseases of public health concern
Guiding health-worker welfare
General
Employment act 2000 Guiding roles and responsibilities of employers and employees
Workers compensation act 1992 Compensation for injuries suffered or diseases contracted by workers in the
course of their employment or for death resulting from such injuries or
diseases
Occupational Safety Act 1997 Regulation of the conditions of employment in workplaces regarding the
safety, health, and welfare of staff
Specific to health workers
Medical practitioners act 1987 Establishes medical council
Nurses and Midwives Act 2002 Regulates training, discipline, registration, and practice of nurses
Code of Ethics for Medical Practitioners and Dentists 1990 Code of ethics and practice for medical practitioners
Infant HBV immunization
Draft EPI Policy Draft, May 2015 Focus on infants < 1 y
Comprehensive EPI Multi-year Plan 2012–2016 Activities promoting infant immunization
National Action Plan on NCDS 2012–2016 Promote cancer preventing vaccines [e.g., HBV vaccine (non-specific on
strategies for infants vs. high-risk groups)]
HBV vaccination of health workers
National care of the carer HIV AIDS workplace policy 2005 Health workers should be provided education, resources (e.g., PPE/AD
syringes), and information on HBV. Health workers should be vaccinated
against HBV. Facilities should train on and provide PEP (not specific if PEP only
for HIV or includes other nosocomial infections (e.g., HBV)]
Infection prevention and control policy 2006 Employers should perform health assessment of new staff, including screening
for HBV. Employer should provide HBV vaccine. Training institutions should
train on infection prevention and include this in curricula. Regulatory
authorities should follow-up to verify that infection prevention is included in
curricula
AD, Auto Disable; EPI, Expanded Program of immunization; HBV, Hepatitis B virus; HIV, human immunodeficiency virus; NCD, non-communicable disease; PPE, personal protective
equipment.
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Table 4 Training institution and district practices for HBV vaccination of health workers and students in Malawi.
Training institution responses
College of Medicine Mulanje Mission Nursing
College
Kamuzu College of Nursing Malawi College of Health
Science
Ownership Government Mission Government Government
Cadres trained Doctor (MBBS), Lab
Technician (MLT),
Physiotherapists,
pharmacists
Nurse Midwives (NMT),
Community Nurse (CMT)
Nurses Paramedical, clinical officer/
medical assistant/ lab
technicians
Written policy No
Immune testing No No No
HBV provided Yes Yes Yes, since 2008 Yes
Free or paying Free Students pay - incorporated in
fees
Free
Mandatory or voluntary Mandatory Mandatory Mandatory, except for those
who are pregnant
Years vaccine provided MLS – Year 1, MBBS and
Pharmacy – Year 3
Year 1 (1st 2 doses provided
within 1st 12 wk of training)
Year 1 (before clinicals)
Years when students start
clinical attachment
MLS – Year 1, MBBS and
Pharmacy – Year 3
Year 1 (after 1st 12 wk) Year 1 (2nd semester)
How are students informed of
vaccine
Reminders sent through
group emails of the next
dose as date approaches
Informed that they will need to
receive vaccine in the offer
letter indicating acceptance
into the school. Provides fee
breakdown. HBV information
and vaccine provided on arrival
All first-year students are
informed about vaccine as part
of their orientation
Does school track who receives Yes. Document all
students who receive
vaccine. No defaulters
School has a register (tracks to
ensure all students get initial 2
doses prior to starting
clinicals). There are some
defaulters (mainly due to fear
of side effects/pain, but these
are counseled to complete
regimen)
Follows up on student
completion of vaccination prior
to attachments
(continued on next page)
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Table 4 (continued)
Training institution responses
College of Medicine Mulanje Mission Nursing College Kamuzu College of Nursing Malawi College of Health
Science
District Responses
Neno Dedza
No. of facilities 14 (9 public, 4 mission, 1
private)
34 (23 public, 11 mission)
Does district provide HBV vaccine Yes, but not routinely due to
cost
Yes
When is it provided Given 3-y ago Currently conducting
vaccination campaign this year
Voluntary vs Mandatory Voluntary Voluntary
Cadres who receive Doctors, nurses, clinical
officers, and medical assistants
Doctors, nurses, clinical
officers, medical assistants,
health surveillance assistants,
support staff, and patient
attendants (only admin staff
excluded). Most staff (all
cadres) had not previously
received vaccine
Provided to all facilities No just at district hospital Yes. All public facilities,
starting with the district
hospital
How is it coordinated Hospital workers are made
aware of vaccine availability,
followed by self-motivated
uptake from pharmacy. No
official tracking of dosage
completion
Coordinated by office of the
District medical officer, HWs
made aware of availability of
vaccine, self-motivated uptake
from OPD, tracking of
completion of doses done via an
improvised register etc.
CMT, community nurse technician; HBV, Hepatitis B virus; MBBS, Bachelor of Medicine and Bachelor of Surgery; MLS, medical laboratory science; MLT, medical laboratory technician;
NMT, nurse midwife technician.
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African health worker HBV vaccination 237tavalent) since 2002 with coverage rates >95%
annually [53], the immunization program does not
provide HBV vaccine to health workers.
Of the nine policies and acts that address
health-worker welfare, two mentioned the HBV
vaccine and mainly mandating ‘‘employers” to pro-
vide the vaccine to newly recruited staff and to
train health workers on risks (Table 3). While the
government is the major employer of health work-
ers in the country due to the decentralized system,
this mandate falls on individual districts to decide
when and how vaccination will be provided. The
regulatory authorities have no explicit mandate
to follow-up if this is done, and their major track-
ing is to ensure training institutions include training
of nosocomial infections in their curricula.
The sampled training institutions did not have
written policies on HBV vaccination for health
workers, but do provide a mandatory HBV vaccine
to students prior to clinical attachment. The
government-run schools provided vaccination free
of charge, while Mulanje Mission included payment
for vaccine as part of the fees. None conducts pre-
or post-testing for immune status (Table 4).
While the Infection prevention policy indicates
the importance of HBV vaccination for healthcare
personnel, it is unclear whether this extends to
cleaners and other staff working in the hospital
environment. As shown in the cases associated with
the sample districts, the policy is interpreted dif-
ferently at ground level (Table 4) and in some dis-
tricts, does not extend beyond the district hospital
setting to smaller facilities.4. Discussion
Our findings showed that, while awareness of HBV
and vaccination was high among health workers,
uptake of the vaccine remained suboptimal in
most countries in the region. A study in Pakistan
identified a similar pattern [54]; however, others
identified poor knowledge in health workers [55–
57] as a key barrier to uptake. A possible explana-
tion for this might be that since our study only
explored awareness and not all aspects of knowl-
edge, there might still be gaps in knowledge in
other areas (e.g., transmission modes, vaccine
characteristics, etc.). Six of the 10 studies that
explored reasons for non-uptake of vaccine cited
inadequate vaccine information as a factor, sug-
gesting that knowledge among health workers
may not be comprehensive.
While there seems to be increasing attempts by
countries to align to WHO recommendations to
make the vaccine available to health workers, ourfindings highlighted the unique and often complex
challenges that the region faces in making this a
reality.
4.1. Vaccination of health workers in
endemic settings
The primary challenge of whether it is necessary to
provide the vaccine in highly endemic settings
where potentially the majority of health workers
may have already been exposed is a critical one
that countries need to address. Studies from Niger
and Cameroon found natural immunity rates (anti-
HBC) >90% [28,43], and, therefore, few health
workers needing vaccination. However, the diver-
sity in HBV endemicity in the region, as seen in
the wide range between 41% in Kenya [48] and
92% in Niger [43], means that ideally each country
would be required to base their vaccination policy
on its local levels of HBV endemicity among health
workers.
According to WHO estimates for the general
adult population, countries in the northern and
western parts of the region (including Cameroon
and Niger) are high endemicity countries, while
the rest of the region is categorized as high inter-
mediate [19]. In the USA and six European coun-
tries, health-worker vaccination is universally
provided without prior testing due to their low
HBV endemicity [58,59], except in special cases.
This means that while universal vaccination of
health workers (without prior immune testing)
can be implemented in intermediate-endemicity
countries in the region (since they will have higher
proportions of susceptible health workers), tar-
geted vaccination after immune testing may be
an option for high-endemicity countries. Pre-
vaccination screening may not only identify those
needing to be vaccinated, but also chronically
infected health workers that may benefit from
antiviral treatment. While the studies above
showed that it is possible to conduct pre-
vaccination screening in a hospital/district setting,
the logistical challenges and financial implications
may limit its feasibility on a national scale. Addi-
tionally, with the increase in infant immunization
in the region, there may be a need to continually
review the strategies of addressing health-worker
immunization as endemicity levels change [31].
4.2. Categorization of which health workers
should receive vaccine
The next challenge is which health workers require
vaccination. While a majority of studies focused on
doctors and nurses, others showed that other
238 B. Malewezi et al.cadres, including medical-waste handlers, mortu-
ary workers, and support staff, were also suscepti-
ble to HBV in the region [23,36,40,45] and could
potentially benefit from vaccination. As shown in
the Malawi case study, without explicit guidelines
on who should receive the vaccine, facilities focus
on clinicians and nurses only, leaving other workers
susceptible. Additionally, in the Malawi case, the
cadres that districts/facilities targeted for on-
the-job vaccination could have potentially already
received vaccination during their training, even
though one district highlighted that most staff
had not previously received the vaccine. WHO does
not recommend booster doses outside of cases
where post-vaccination immune testing shows
insufficient immune response [60]. Some settings
stratify which health workers are vaccinated by
type of work carried out in the hospital. However,
the Centers for Disease Control guidelines make
provisions that decisions regarding which addi-
tional health workers receive the vaccination can
be guided by the facility [58], so potentially all
workers in a hospital (including administrative
staff) can receive the vaccine as was reported by
some study sites [34]. Additionally, because stu-
dents are often at higher risk for injuries (due to
their inexperience), prioritizing vaccination while
undergoing training is a key strategy that can opti-
mize protection of health workers.
4.3. Competing priorities
While hepatitis is receiving more attention on a
global scale, countries often have competing prior-
ities in the health sector, as shown in a Malawi case
where there was little-to-no mention of HBV in the
key documents guiding the sector. Diseases, such
as HIV, malaria, and tuberculosis, often have a
more prominent focus in the region, meaning that
resources for HBV prevention may be limited.
While Gavi (the Vaccine Alliance) has assisted sev-
eral countries in the region to introduce HBV vacci-
nation (in a combined form, as Pentavalent) for
infants at a subsidized cost [2], there is no provi-
sion for vaccination of health workers. Countries
would have to bear this cost, which could be
restrictive, especially if coverage of this cost is
then required of the health worker.
4.4. Implementation challenges
Apart from cost, other challenges identified, such
as lack of awareness of vaccine availability, poor
vaccination-completion rates, and lack of explicit
treatment options for exposed health workers,
are also pertinent issues that any country in theregion developing a policy for HBV vaccination of
health workers needs to address. As shown in the
two studies aimed at raising vaccine uptake
[34,48], voluntary uptake rates can be relatively
adequate where deliberate measures are imple-
mented to make the vaccine available and increase
vaccine awareness/knowledge among health
workers.
There is often debate as to whether vaccination
of health workers should be mandatory or volun-
tary, but both are possible in various settings [59]
and as shown in the Malawi case study, where both
strategies were used at different levels. None of
the studies in our sample compared the strategies
in terms of cost, uptake, or other factors. The vol-
untary or ‘‘opt in” strategy, where the institution
has the vaccine, but it is up to the health worker
to request vaccination, can raise uptake, but may
have varying results at different healthcare levels
[48]. Introduction of policies that mandate or
encourage HBV vaccination in the workplace can
result in a higher vaccination coverage [60].
Mandatory or ‘‘opt out” strategies, where the vac-
cine is offered to all eligible health workers and
those who do not want to be vaccinated can choose
not to receive it, were successful at increasing flu-
vaccine coverage among health workers in a study
in the USA [61]. Choosing which option to imple-
ment will be guided by the overarching laws and
principles that guide freedom of choice/public
health in each country.
WHO encourages innovative approaches to HBV
vaccination, and our findings reiterate that a
‘‘one size fits all” policy cannot work across the
region. Therefore, countries will need to develop
unique and often targeted strategies to suit their
specific country context.
4.5. Recommendations
While awareness of HBV and vaccination may be
high, it is not sufficient to force increased vaccine
uptake, therefore, more comprehensive measures
addressing other barriers, such as cost and avail-
ability, to ensure uptake and compliance may need
to be incorporated.
Where feasible, providing HBV vaccination as
part of the default package of provisions for health
workers via mandatory/‘‘opt out” strategies may
be effective in the region.
4.6. Study limitations
While our study provided an overview of findings
related to health-worker HBV vaccination in the
region, it had a number of limitations. There have
African health worker HBV vaccination 239been many changes in policies and modalities
regarding HBV vaccination, especially following
the WHO 2010 resolution [62]. Due to the 150-
year span utilized in our study, older studies may
not be reflective of current trends in the countries.
However, only 12 of the 33 studies included were
published prior to 2010; therefore, the majority
of the studies were more recent and likely to
reflect the current status of the countries. There
was also variability within the studies on how some
factors were categorized (e.g., vaccination status,
knowledge, etc.). During data extraction and
cleaning, we standardized terminology to cate-
gories that were more consistent across the stud-
ies. Finally, due to our small sample for the
Malawi case study, findings from the training insti-
tutions and districts may not be reflective of all the
facilities, and would likely benefit from a larger
study to fully explore practices across the country.
Despite these limitations, our study provided a
succinct summary on issues related to health-
worker vaccination for HBV and context for further
discussion and research on the topic in the region,
including exploring cost implications for mandatory
versus voluntary policies and how these affect
uptake.
4.7. Conclusion
Countries in the Sub-Saharan region who want to
implement HBV vaccination of health workers will
need to base their strategies on local epidemiology
and guiding principles. Such plans ideally should be
guided by locally relevant evidence and experts
and should be comprehensive (not just vaccination,
but treatment and addressing of factors limiting
uptake) and consistently applied throughout each
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